A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy

被引：0
|
作者：
Tianhong Yang
Lei Peng
Jia Qiu
Xingjin He
Dake Zhang
Renbo Wu
Jianbo Liu
Xiangsong Zhang
Zhihao Zha
机构：
[1] The First Affiliated Hospital of Sun Yat-Sen University,Department of Nuclear Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Silicon-fluoride-acceptor; FAP inhibitor; Radiohybrid; Theranostics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2331 / 2341
页数：10
相关论文
共 3 条
  • [1] A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy
    Yang, Tianhong
    Peng, Lei
    Qiu, Jia
    He, Xingjin
    Zhang, Dake
    Wu, Renbo
    Liu, Jianbo
    Zhang, Xiangsong
    Zha, Zhihao
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2331 - 2341
  • [2] Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04
    Kuyumcu, Serkan
    Kovan, Bilal
    Sanli, Yasemin
    Buyukkaya, Fikret
    Simsek, Duygu Has
    Ozkan, Zeynep Gozde
    Isik, Emine Goknur
    Ekenel, Meltem
    Turkmen, Cuneyt
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : 641 - 646
  • [3] Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT
    Isik, Emine Goknur
    Has-Simsek, Duygu
    Sanli, Oner
    Sanli, Yasemin
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E54 - E55
1